by Innovit Corporate Affairs | Jul 7, 2025 | Blog, GDSN, Michelle Laurion
With Innovit’s expertise, our client achieved all goals and completed M2M tests with AusUDID and EUDAMED Innovit is proud to announce that one of our clients, a global medical device company and leader in orthopedic devices, was the first to complete M2M testing...
by Innovit Corporate Affairs | Aug 17, 2022 | Blog, GDSN, Michelle Laurion
Getting Started With the GDSN In our previous blog, we discussed what the GDSN is. In today’s blog, we’ll go over what companies can expect and should prepare for when starting their GDSN journey. As with any journey, how you start can make a big difference,...
by Innovit Corporate Affairs | Aug 9, 2022 | Blog, GDSN, Michelle Laurion
Announcing Innovit’s GDSN Blog Series! Sharing information about products and devices is a cornerstone of modern supply chains, regulatory compliance departments and ecommerce platforms. There are several options to facilitate this sharing, from point-to-point...
by Innovit Corporate Affairs | Jul 29, 2022 | Blog, Michelle Laurion
On July 22, the FDA posted its final guidance regarding Global Unique Device Identification Database (GUDID) submission requirements for certain Class I devices considered consumer health products. The guidance document, “Unique Device Identification: Policy Regarding...
by Innovit Corporate Affairs | Sep 4, 2021 | Blog
EUDAMED timelines are quickly approaching, and UDI data preparation is no easy task. Preparing early with a master data strategy will make all the difference when mandates for EUDAMED and other health authorities come due. A large component of that strategy centres...
